Bad Heilbrunn, Germany

Klaus Kaluza

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Habach, DE (1992 - 1993)
  • Bad Heilbrunn, DE (1992 - 2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Klaus Kaluza

Introduction

Klaus Kaluza, an inventive mind hailing from Bad Heilbrunn, Germany, has made significant contributions to the field of biochemical research through his numerous patents. With a total of ten patents to his name, Kaluza's work primarily revolves around enzyme technologies and their applications in DNA processing and cholesterol determination.

Latest Patents

Among Klaus Kaluza's notable innovations is the patent for "Thermolabile uracil-DNA-glycosylase, process for its preparation and use for removing uracil from DNA." This thermolabile enzyme exhibits uracil-DNA-glycosylase activity, characterized by a high degree of purity, short half-lives, and minimal contaminating foreign activities—specifically less than 2%. The enzyme is derived from gram-positive microorganisms such as Arthrobacter or Micrococcus, highlighting the biotechnological advancements in enzymatic applications for PCR products. Another significant patent is for the "Microbial cholesterol dehydrogenase, process for its production and use," which details an oxygen-independent cholesterol-converting enzyme sourced from Actinomycetes or Basidiomycetes. This enzyme employs artificial electron acceptors and includes methods and reagents for the determination of total cholesterol, showcasing Kaluza's innovative approach to biomedical diagnostics.

Career Highlights

Throughout his career, Kaluza has worked with prominent companies such as Boehringer Mannheim GmbH and Roche Diagnostics GmbH. These positions allowed him access to cutting-edge research environments where his patented technologies have flourished. His work at these companies has not only propelled his inventions but has also contributed significantly to advancements in diagnostics and enzymatic processes on a broader scale.

Collaborations

Kaluza has collaborated with esteemed colleagues including Michael Jarsch and Bruno Frey. These partnerships have played a vital role in refining and advancing his research, amplifying the impact of his inventions within the scientific community.

Conclusion

Klaus Kaluza stands out as a pivotal figure in the realm of biochemistry and enzymatic innovation. His renowned patents, coupled with his collaborative contributions, reflect his unwavering commitment to advancing scientific knowledge and providing practical solutions to complex biological challenges. As the field continues to evolve, Kaluza’s innovations are likely to remain influential for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…